Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Maxim Hot 100

The world's most beautiful women as chosen by Maxim readers.  Slideshow 

Shreen Mohammad sits with other recruits during a military exercise at the Kabul Military Training Center (KMTC) in Kabul March 28, 2012. A landmark NATO summit in Chicago endorsed an exit strategy that calls for handing control of Afghanistan to its own security forces by the middle of next year but left questions unanswered about how to prevent a slide into chaos and a Taliban resurgence after allied troops are gone. Picture taken March 28, 2012.   REUTERS/Omar Sobhani (AFGHANISTAN - Tags: POLITICS MILITARY SOCIETY) ATTENTION EDITORS: PICTURE 18 OF 27 FOR PACKAGE 'AFGHAN ARMY RECRUIT'

Afghan army recruit

A look at an Afghan recruit as he goes through the process of joining the Afghan National Army.  Slideshow 

Diabetes "massive challenge" as cases hit 366 million

Related Topics

A woman has her finger pricked for a blood sugar test in the Family Van in Boston, Massachusetts, August 9, 2010. REUTERS/Brian Snyder

A woman has her finger pricked for a blood sugar test in the Family Van in Boston, Massachusetts, August 9, 2010.

Credit: Reuters/Brian Snyder

LONDON | Tue Sep 13, 2011 7:36am EDT

LONDON (Reuters) - The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide, experts said on Tuesday.

The vast majority of those with the disease have Type 2 -- the kind linked to poor diet, obesity and lack of exercise -- and the problem is spreading as people in the developing world adopt more Western lifestyles.

Diabetics have inadequate blood sugar control, which can lead to serious complications like heart disease and stroke, damage to the kidneys or nerves, and to blindness. Worldwide deaths from the disease are now running at 4.6 million a year.

The latest figures, unveiled at the European Association for the Study of Diabetes (EASD) congress in Lisbon, underline the need for urgent action by governments at a U.N. meeting next week, according to top doctors in the field.

The high-level United Nations meeting in New York on September 19-20 -- only the second to focus on disease after one on AIDS in 2001 -- will consider what should be done to counter the growing problem of non-communicable diseases (NCDs), including diabetes.

Food, drinks and tobacco companies are in the firing line for selling products linked to cancer, heart disease and diabetes, but health campaigners fear politicians may not set firm targets or provide funds for a decent fight.

The NCD Alliance, which groups 2,000 health organizations from around the world, argues that spending $9 billion a year on tobacco control, food advice and basic treatments would avert tens of millions of untimely deaths this decade.

Cash-strapped governments, however, have baulked at finding new money, though the cost of inaction may be even greater, with annual healthcare spending on diabetes alone now put at $465 billion.

The new figures on the prevalence and cost of diabetes are to be published in the fifth edition of the Diabetes Atlas, the authoritative guide to the disease issued by the International Diabetes Federation (IDF).

The previous edition in October 2009 had estimated the number of diabetics at 285 million for 2010, although a separate study published in the Lancet medical journal in June this year had already put the figure at a much higher 347 million.

"The IDF's latest Atlas data are proof indeed that diabetes is a massive challenge the world can no longer afford to ignore. In 2011 one person is dying from diabetes every seven seconds," said IDF President Jean Claude Mbanya.

Mbanya and EASD Vice-President Andrew Boulton said more research was needed into strengthening health systems around the world to deal with diabetes.

Many older classes of diabetes drugs are now available as cheap generics, but global drugmakers -- including Sanofi, Eli Lilly and Novo Nordisk -- aim to introduce new classes of drugs that could further extend treatment options.

Global sales of diabetes medicines totaled $35 billion last year and could rise to as much as $48 billion by 2015, according to research firm IMS Health, driven by increased prevalence and treatment, especially in countries such as China, India, Mexico and Brazil.

(Editing by Will Waterman)

Related Quotes and News

Company
Price
Related News
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (8)
bondgirly007 wrote:
Maybe because our “leaders” have oh so wisely let food companies lace EVERYTHING with sugar. They don’t even call it sugar anymore, they come up with a new name for it every month. Dextros this and sucrose that, who can keep up?

Sep 13, 2011 6:59am EDT  --  Report as abuse
moonhill wrote:
It would help if we got rid of high fructose corn syrup. You would be surprised how many products have this ingredient.

Sep 13, 2011 12:32pm EDT  --  Report as abuse
Sacados wrote:
I don’t think sugar is the only source of the problem. Overeating in general, which leads to obesity, seems to be the biggest issue. Maintaining a normal weight is the way to beat this disease. On the other hand, we have so many people on this Earth thanks to medical miracles, it might be Nature’s way of population control.

Sep 13, 2011 2:50pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.